Table 4 Clinical sensitivity, clinical specificity, relative risk, and attributable risk for severe bleeding events (wild vs. nonwild CYP2C9 genotype)

From: A Rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding